2016 Annual Tuberculosis Report For Fresno County

Size: px
Start display at page:

Download "2016 Annual Tuberculosis Report For Fresno County"

Transcription

1 206 Annual Tuberculosis Report For Fresno County

2 Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis Cases and Rates in Fresno County Tuberculosis (TB) is a common communicable disease caused by the bacterium Mycobacterium tuberculosis and occasionally Mycobacterium bovis. It most commonly infects the lungs, but can infect almost any organ system. In 206, 60 new cases of active TB were diagnosed in Fresno County (6. per 00,000 population); a 42.9% increase in the annual number of cases from 205 (Figure ). Out of the 6 health jurisdictions in California, Fresno County ranked 0 th for active TB cases, representing 2.9% of all California cases Figure. Annual TB Case Counts and Rate - Fresno County, Cases Rate CA 209 Goal 0 Demographic Characteristics In 206, 44 (73.3%) cases were male and 6 (26.6%) were female. Most TB cases occur in older adults and in Fresno County, 32 (53.3%) were over the age of 50 (Figure 2). Only 3 TB patients were under the age of five. The average age of TB patients in Fresno County during 206 was 50.4 years with a range from to 95 years. In 206, 6 (26.7%) TB cases were among US-born residents, while the remaining 43 (7.7%) were among foreign-born persons (Figure 3). The nativity of (.7%) TB patient is unknown. The majority of foreign-born cases 48.8% (n=2) arrived from Mexico, and others arrived from: India 8.6% (n=8), Laos 6.3% (n=7), Philippines 7.0% (n=3), Cambodia 2.3% (n=), Vietnam 2.3%

3 Cases (n=), El Salvador 2.3% (n=), and Nigeria 2.3% (n=) (Figure 3). Foreign born TB patients spent an average of 29.3 years in the US prior to their TB diagnosis. Figure 2: Age Distrubtion of TB Cases in Fresno County Age Range (years) Figure 3: TB Cases by Nativity and Country of Origin - Fresno County, 206. Unknown.7%(n=) Nigeria 2.3%(n=) Native Born 26.7%(n=6) Mexico 48.8%(n=2) Philippines 7.0%(n=3) Vietnam 2.3%(n=) Foreign Born 7.7%(n=43) Laos 6.3%(n=7) India 8.6%(n=8) Cambodia 2.3%(n=) El Salvador 2.3%(n=)

4 Case Rate (Per 00,000 people) Racial and ethnic disparities exist among populations with TB disease in Fresno County (Figure 4 & Figure 5). The combined TB incident rate in Fresno County for 206 is 6. per 00,000 people. That rate for Asian/Pacific Islanders, Blacks/African Americans, Hispanics/Latinos, and Whites is: 25.8, 8.8, 5.7, and.3 per 00,000 people respectively (Table ). The proportion of the total Fresno County population represented by each race/ethnicity is at the far right of Table. Figure 4: TB Cases by Race/Ethnicity - Fresno County, 206. Black/African American 7%(n=4) Hispanic/Latino 46%(n=28) White 7%(n=4) Asian/Pacific Islander 40%(n=24) Figure 5: Incident Rates of TB by Race/Ethnicity - Fresno County, Asian/Pacific Islander Black/African American Hispanic/Latino White

5 Cases Table : Incident Rates of TB by Race/Ethnicity - Fresno County, 206. Race/Ethnicity Cases Incidence Rate* % Population** Asian/Pacific Islander Black/African American Hispanic/Latino White *Per 00,000 people. **Population estimates retrieved from Figure 6 shows the occupational status of those with TB disease in Fresno County during 206. Most cases, 60.0% (n=36), were not employed because they were: not seeking work 33.3% (n=20), retired 2.6% (n=3) or unemployed 5.0% (n=3). Those employed with a TB diagnosis represent 40.0% (n=24) of cases. 30 Figure 6: Occupational Status of TB Cases - Fresno County, Working Not Seeking Work Retired Unemployed 3

6 Figure 7: TB Cases by Zip Code - Fresno County, 206.

7 Case Referral by Source Cases of TB were referred to the Fresno County Department of Public Health from different sources. Of the 60 cases, 80% (n=48) were referred by hospitals, 3% (n=8) by private doctors, 5% (n=3) by contact investigation, and 2% (n=) as lab referrals (Figure 8). Figure 8: Referral Souces for TB Cases - Fresno County, 206. Contact Investigation 5%(n=3) Hospital 80%(n=48) Lab 2%(n=) Private Doctor 3%(n=8) Pathology and Organism Characteristics Forty-eight (80.0%) patients had lung involvement, of which 45 (75.0%) had lung involvement only. Of these 48, three had pulmonary infection combined with infection in: bone in case (.7%), cervical lymph nodes in case (.7%), and genitourinary involvement in case (.7%). Twelve patients (20.0%) had extrapulmonary infection in the: cervical lymph nodes 5 (8.3%), lung pleura 4 (6.7%), axillary lymph nodes (.7%), and bone (.7%) tissues (Table 2). Table 2: Cases of TB by Site of infection Fresno County, 206. Infection Site* Cases Pulmonary Cervical Pleural Axillary Bone Peritoneal Genitourinary *A blue box indicates infection and a grey box indicates no infection.

8 Culture positive results were obtained on 78.3% (n=47) of the 60 TB patients. Of these, drug susceptibility results are available for 87.2% (n=4) cases. No drug resistance was observed in 80.4% (n=33) of cases, while the remaining 9.5% (n=8) of cases showed resistance to: Isoniazid 7.3% (n=3), Isoniazid + Streptomycin 2.4% (n=), Isoniazid + Ethionamide 2.4% (n=), Rifampin 2.4% (n=), Streptomycin 2.4% (n=), and Pyrazinamide 2.4% (n=) (Table 3). No cases of TB in 206 were multi-drug resistant (MDR) or extensively drug resistant (XDR). Table 3: Drug Resistance Profile for TB Cases - Fresno County, 206. Tuberculosis Drug* Cases Isoniazid Rifampin Streptomycin Ethionamide Pyrazinamide 33 3 *A blue box indicates resistance and a grey box indicates no resistance. Tuberculosis has different strains or lineages that can be determined through genotyping. When two or more TB cases share the same genetic strain or lineage, they potentially became infected through a common source. The TB program can use genetic links between TB cases to investigate and stop common sources of transmission. Figure 9 shows the proportion of each lineage in TB cases sent for genotyping from During 206, 85% (n=5) of cases were genotyped and composed of four lineages: EuroAmerican 58.8% (n=30), IndoOceanic 7.6% (n=9), East Asian 5.6% (n=8), and East African Indian 7.8% (n=4). 00% 80% 60% 40% 20% Figure 9: Proportion of Different TB Lineages - Fresno County, % EuroAmerican East Asian IndoOceanic East African Indian Bovis

9 Contributing Risk Factors During 206, 55 (9.6%) of the 60 TB cases had at least one or more underlying factor that increased risk for TB infection or progression of infection to disease whether it be occupational, social, or medical (Tables 4 & Table 5). For those TB patients with chronic medical issues, 28.0% (n=7) had at least one or more comorbidity. Other known risk factors for TB disease not present in the 206 cases include: Prednisone treatment, TNF-α antagonist treatment, smoking, being underweight and incarceration. Table 4: Occupational and Social Risk Factors that Increase Risk for TB Infection by Nativity - Fresno County, 206. Risk Characteristic U.S. Born N Foreign Total N (%) (%) Born N (%) Health Care Worker 0 (0.0%) (.6%) (.6%) Migrant/Seasonal Worker 0 (0.0%) 0 (6.6%) 0 (6.6%) Homeless 2 (3.3%) 3 (5.0%) 5 (8.3%) Resident Long Term Care 4 (6.6%) 0 (0.0%) 4 (6.6%) Facility Contact To Infectious TB 6 (0.0%) 0 (0.0%) 6 (0.0%) Table 5: Medical Risk Factors that Increase Risk for TB Infection Progressing to TB Disease - Fresno County, 206. Comorbidity U.S. Born N Foreign Total N (%) (%) Born N (%) Diabetes (.6%) 0 (6.6%) (8.3%) End Stage Renal Disease 0 (0.0%) 2 (3.3%) 2 (3.3%) HIV Positive (.6%) (.6%) 2 (3.3%) Immunosuppression (.6%) 0 (0.0%) (.6%) Alcohol Abuse 0 (0.0%) 5 (8.3%) 5 (8.3%) Drug Abuse 0 (0.0%) (.6%) (.6%) TB Reactivation 0 (0.0%) (.6%) (.6%)

10 Percent Percent Of the 60 TB patients in 206, 54 were eligible for HIV testing and all of them completed testing. Six cases (0%) were excluded from HIV testing because they either died before testing (n=4), or were younger than age five without risk factors for HIV (n=2) (Figure 0) Figure 0: Proportion of TB Patients with Known HIV Status (Positive or Negative) Fresno County, % Reported Positive or Negative CA 209 Goal Treatment Outcomes Of the 60 cases of TB in Fresno County during 206, 28 had positive sputum culture results at the time of treament initation. After 60 days of treament, 20 (7.4%) patients had sputum-culture negative results indicating they were no longer contagious for TB (Figure ) Figure : Proportion of TB Patients with Sputum Culture Conversion Within 60 Days - Fresno County, % Converted 60 Days CA 209 Goal

11 Percent Treatment courses for TB are long and standard treatment regimens are 6-2 months; furthermore, drug resistant TB patients may be treated for up to two years. Due to the long time frame for treatment, data for 206 treatment completion is not available at the time of this report; however, this information is available for the 205 TB cohort. During 205, 85.7% (n=36) of the 42 TB patients were eligible to complete their treatment within a 2 month period. Of these 36 patients, 9.7% (n=33) completed their treatment within one year (Figure 2). The remaining nine TB patients: completed treatment after 2 months.9% (n=5), 7.% (n=3) died, and 2.3% (n=) were unable to complete therapy. The one patient that did not complete therapy left the United States before treatment completion. Delays or intermittent interruptions in treatment can result from factors such as: multidrugresistant TB, patient non-compliance, underlying health conditions, and adverse effects of medication. Figure 2: Proportion of Fresno County TB Patients Completing Treatment in 2 Months or Less, * Completed Treatment 2 Months CA 209 Goal % *For patients with TB in which 2 months or less of treatment was indicated. In late 205, the TB Control Program began documenting 3HP treatment completion in LTBI patients (Figure 3). 3HP treatment is one treatment method for LTBI and requires patients take Isoniazid and Rifapentine antibiotics once weekly for twelve weeks. Between September December of 205, LTBI patients began treatment, 8.8% (n=9) finished treatment, and 8.2% (n=2) did not finish treatment. In 206, 40 LTBI patients began 3HP treatment. Of these 90.7% (n=27) finished treatment and 9.3% (n=3) did not finish treatment.

12 Percent Percent Figure 3: Proportion of LTBI Patients with 3HP* Treatment Completion - Fresno County, Completed Treatment Completed Treatment 2 Weeks Did Not Complete *3HP treatment consists of a once weekly dose of Isoniazid and Rifapentine for 2 weeks. 9.3 Contact Investigation Contact investigation data for 206 is not available at the time of this report; however, this information is available for the 205. During 205, 52.3% (n=22) of 42 TB cases were AFB smear-positive and 00% of these cases had contacts elicited for investigation. Out of the 56 AFB smear-positive contacts elicited, 76.6% (n=395) were examined for TB infection (Figure 4). Of the AFB smearpositive contacts examined in 205, 8.2% (n=72) were discovered to have LTBI infection and 73.6% (n=53) of these patients began treatment (Figure 5) Figure 4: Contacts to AFB Smear Positive Cases Examined for TB - Fresno County, % AFB Smear + Contacts Examined CA 209 Goal

13 Percent Figure 5: Contacts to Sputum AFB Smear Positive TB Cases with LTBI Treatment Status Fresno County, Started Treatment Did Not Start Treatment CA 209 Goal %

14 Tuberculosis Burden in Fresno County In 206, the Fresno County Health Department s TB Control Program provided treatment, contact investigation, and follow-up for all the 60 newly diagnosed active TB cases. The TB program staff continued to simultaneously provide care for patients diagnosed prior to 206 who had not yet completed treatment (standard treatment regimens are 6-2 months; drug resistant TB patients may be treated for two years and all require at least monthly visits). To ensure TB medication is taken correctly, department staff visit pulmonary TB patients daily to observe them take their medications; this is also known as Direct Observed Therapy (DOT). Tuberculosis Burden at Global, National and State Levels Global Tuberculosis (TB) is one of the world s deadliest diseases and one-third of the population has latent TB infection. During 205, 0.4 million people developed active TB resulting in.8 million deaths from the illness. TB is especially known to impact low and middle income countries where 95 percent of cases occur. TB is a leading killer of people who are HIV infected, and in 205, 35% of HIV deaths were due to TB complications globally. National A total of 9,557 TB cases (a rate of 3.0 cases per 00,000 persons) were reported in the United States in 205. This is a.6% increase in TB cases from 204, however; the incident rate has remained stable at around 3.0 cases per 00,000 people since 203. TB persists at greater incidence rates in specific populations such as those who are foreign born and in racial/ethnic minorities. California In 205, a total of 2,33 cases were reported compared to 234 cases in 204. Twenty percent of the nation s TB cases were reported from California during 205. The decrease in the TB incident rate in California has slowed over the past decade and flattened during 205. During , the annual TB rate remained at 5.5 cases per 00,000 people. Tuberculosis cases were reported in 42 of California s 6 (69%) local health jurisdictions. Twelve of 27 (44%) local health jurisdictions with at least 5 cases in 205, had an increase in cases compared to 204 An estimated 2.4 million Californians (6%) are infected with latent TB and at risk of developing active TB if not properly diagnosed and treated. Among this group,

15 only 3% have been treated and only 23% are aware of their infection. Latent TB treatment is critical because an estimated 80% of active TB cases develop from latent TB infections. Multidrug-resistant TB (MDR TB) is resistant to the strongest two primary antituberculosis medications (isoniazid and rifampin), and extensively drug resistant TB (XDR TB) organisms are resistant to these medications plus at least two of the principal secondary medications. Patients with XDR TB have few treatment options because the drugs most effective against TB are ineffective against their disease. In California, MDR TB has remained a small proportion of TB cases (- 2%) during despite the growth of MDR TB cases throughout the world. The majority (85%) of California counties with reported TB cases have had at least one MDR TB case in the last 7 years ( ). No Extensively Drug Resistant (XDR) TB cases were reported in California during 205 and only 3 XDR TB cases were reported in California during Sources: World Health Organization: Centers for Disease Control: California Tuberculosis Control Branch: Public Health Strategies to Control, Prevent, and Eliminate Tuberculosis Include: - Finding and adequately treating persons that have active disease 2- Identifying individuals who have been exposed to someone with TB disease, evaluating them for TB infection or TB disease, and treating them if they have either of these. 3- Screening individuals for TB infection that are known to be at higher risk for infection with TB or at higher risk for developing TB disease if infected. 4- Applying control measures in high risk settings. The FCDPH Chest Clinic Program identifies and treats TB disease, identifies and evaluates exposures to TB and offers treatment if needed, screens certain high risk populations, and assists the public with the application of control measures in high risk environments. Title 7 of California Code of Regulations requires that notification be given to the county health department of all diagnosed or suspicious cases of tuberculosis by telephone or fax within one working day of identification. California Health and Safety Code 2362 also require that providers treating persons with active TB report to the local health officer any pertinent information the health officer requests. Additional Information Available If you have any questions regarding TB infection or disease or the control of TB in Fresno County please contact our Community Liaison Nurse at

2014 Annual Report Tuberculosis in Fresno County. Department of Public Health

2014 Annual Report Tuberculosis in Fresno County. Department of Public Health 214 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org Tuberculosis (TB) is a common communicable disease caused by the bacterium Mycobacterium tuberculosis and occasionally

More information

2015 Annual Report Tuberculosis in Fresno County. Department of Public Health

2015 Annual Report Tuberculosis in Fresno County. Department of Public Health 215 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org Number of Cases Rate per 1, Population 215 Tuberculosis Annual Report Fresno County Department of Public Health

More information

2013 Annual Report Tuberculosis in Fresno County. Department of Public Health

2013 Annual Report Tuberculosis in Fresno County. Department of Public Health 2013 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org In 2013, provisional data indicates that tuberculosis (TB) affected 3.0 / 100,000 people in the United States

More information

TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology

TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology TB EPIDEMIOLOGY TB Clinical Intensive Course Curry International Tuberculosis Center September 30, 2015 Varsha Nimbal, MPH Tuberculosis Control Branch California Department of Public Health 1 Outline TB

More information

Tuberculosis Epidemiology

Tuberculosis Epidemiology Tuberculosis Epidemiology TB CLINICAL INTENSIVE COURSE Curry International Tuberculosis Center October 18, 2017 Varsha Hampole, MPH Tuberculosis Control Branch California Department Of Public Health Outline

More information

The Epidemiology of Tuberculosis in Minnesota,

The Epidemiology of Tuberculosis in Minnesota, The Epidemiology of Tuberculosis in Minnesota, 2011 2015 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) 201-5414 Tuberculosis surveillance data for Minnesota are available

More information

Tuberculosis in Chicago 2007

Tuberculosis in Chicago 2007 City of Chicago Communicable Disease Information Department of Public Health Richard M. Daley, Mayor May 2008 Terry Mason, MD, FACS, Commissioner www.cityofchicago.org/health/ West Side Center For Disease

More information

I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female %

I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES. Male % Female % San Joaquin County (SJC) in 03, (N=43) County Rate = 6. Cases per 00,000 Population I. Demographic Information Table I-A: TB cases by gender, SJC, 03 (N=43) GENDER NUMBER OF CASES Male 6 60.5% Female 7

More information

Arizona Annual Tuberculosis Surveillance Report

Arizona Annual Tuberculosis Surveillance Report Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case

More information

Annual Tuberculosis Report Oregon 2007

Annual Tuberculosis Report Oregon 2007 Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page

More information

2014 TUBERCULOSIS FACT SHEET A Profile of Mecklenburg County Reported Cases

2014 TUBERCULOSIS FACT SHEET A Profile of Mecklenburg County Reported Cases OVERVIEW T uberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. TB usually affects the lungs, but it can also affect other parts of the body. TB is spread through the air

More information

Tuberculosis Populations at Risk

Tuberculosis Populations at Risk Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading

More information

Tuberculosis in Alameda County, 2009

Tuberculosis in Alameda County, 2009 Tuberculosis in Alameda County, 29 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a communicable disease caused by the bacteria Mycobacterium tuberculosis. TB is spread

More information

Summary Statistics of Reported and Verified Cases of Tuberculosis in San Joaquin County in 2012, (N=44) County Rate = 6.3 Cases per 100,000 Population

Summary Statistics of Reported and Verified Cases of Tuberculosis in San Joaquin County in 2012, (N=44) County Rate = 6.3 Cases per 100,000 Population I. Demographic Information GENDER NUMBER OF CASES PERCENT OF CASES Male 29 65.9% Female 15 34.1% AGE GROUP NUMBER OF CASES PERCENT OF CASES 04 3 6.8% 514 2 4.5% 1524 3 6.8% 2544 6 13.6% 4564 15 34.1% 65+

More information

ANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012

ANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012 ANNUAL TUBERCULOSIS REPORT OREGON 211 Oregon Health Authority Public Health Division TB Program November 212 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-211... page

More information

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of

More information

ACTIVE TUBERCULOSIS IN MACOMB COUNTY, A Review of TB Program Data,

ACTIVE TUBERCULOSIS IN MACOMB COUNTY, A Review of TB Program Data, ACTIVE TUBERCULOSIS IN MACOMB COUNTY, 1996-2010 A Review of TB Program Data, 1996-2010 Prepared by: Janice M. Chang, MBBS, MPH Division Director, Health Promotion and Disease Control Macomb County Health

More information

TB trends and TB genotyping

TB trends and TB genotyping Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures

More information

Tuberculosis in Chicago 2006

Tuberculosis in Chicago 2006 Chicago Department of Public Health May 27 Communicable Disease Information Tuberculosis in Chicago 26 City of Chicago Richard M. Daley, Mayor Department of Public Health Terry Mason, MD, FACS Commissioner

More information

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis? Tuberculosis Understanding, Investigating, Eliminating Jeff Maupin, RN Tuberculosis Control Nurse Sedgwick County Division of Health Objectives At the conclusion of this presentation, you will be able

More information

Haley Blake Sage Nagai, MPH. Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic

Haley Blake Sage Nagai, MPH. Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic Haley Blake Sage Nagai, MPH Disease Investigation and Intervention Specialists Tuberculosis Treatment and Control Clinic Discuss the prevalence of tuberculosis in Clark County Describe factors influencing

More information

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

TUBERCULOSIS. Presented By: Public Health Madison & Dane County TUBERCULOSIS Presented By: Public Health Madison & Dane County What is Tuberculosis? Tuberculosis, or TB, is a disease caused by a bacteria called Mycobacterium tuberculosis. The bacteria can attack any

More information

Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)

Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254) Tuberculosis Reporting, Waco-McLennan County Public Health District TB Control WMCPHD (254)-750-5496 Local health care providers, including physicians offices, labs and hospitals, are required by law to

More information

Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination

Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination IUATLD North American Region Conference February 24, 2017 Vancouver, BC Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination Philip LoBue, MD National Center

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

Yakima Health District BULLETIN

Yakima Health District BULLETIN Yakima Health District BULLETIN Summary Volume 13, Issue 1 February, 2014 Tuberculosis in Yakima County The rate of active tuberculosis (TB) in Yakima County has declined by about two-thirds over the past

More information

Tuberculosis in Alameda County, 2012

Tuberculosis in Alameda County, 2012 Tuberculosis in Alameda County, 212 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a preventable and curable disease that remains one of the leading causes of death

More information

Tuberculosis in Alameda County, 2014 Alameda County Public Health Department

Tuberculosis in Alameda County, 2014 Alameda County Public Health Department Tuberculosis in Alameda, 214 Alameda Public Health Department Tuberculosis (TB) is a preventable and curable disease that remains one of the leading causes of death worldwide. TB is a communicable disease

More information

2008 Tuberculosis Report

2008 Tuberculosis Report 2008 Tuberculosis Report County of Sacramento Department of Health and Human Services Division of Public Health Page 1 Table of Contents Figure 1. Tuberculosis Incidence Rates, County of Sacramento Vs

More information

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Chapter 1 Overview of Tuberculosis Epidemiology in the United States Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States... 3 TB Disease Trends in the United

More information

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening

More information

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016

Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No

More information

Tuberculosis: A Provider s Guide to

Tuberculosis: A Provider s Guide to Tuberculosis: A Provider s Guide to Diagnosis and Treatment of Active Tuberculosis (TB) Disease and Screening and Treatment of Latent Tuberculosis Infection (LTBI) Alameda County Health Care Services Agency

More information

TUBERCULOSIS CONTACT INVESTIGATION

TUBERCULOSIS CONTACT INVESTIGATION TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used

More information

Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal

Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal Civil surgeons are required to report tuberculosis (TB) screening outcomes that result in latent TB

More information

Tuberculosis Impact in Boston Residents: 2012

Tuberculosis Impact in Boston Residents: 2012 Tuberculosis Impact in Boston Residents: 2012 BOSTON PUBLIC HEALTH COMMISSION Infectious Disease Bureau Communicable Disease Control Division Number of TB Cases: Boston, 1995-2012 200 180 160 140 Number

More information

TB in California: Costs, Transmission, and Selecting from the Latent Pool

TB in California: Costs, Transmission, and Selecting from the Latent Pool TB in California: Costs, Transmission, and Selecting from the Latent Pool Pennan Barry, MD, MPH Tuberculosis Control Branch California Department of Public Health California Tuberculosis Controller s Association

More information

Fundamentals of Tuberculosis (TB)

Fundamentals of Tuberculosis (TB) TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported

More information

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 1 Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 Daniel P. Dohony, MPH Division of Tuberculosis Elimination Centers for Disease Control and Prevention and Philadelphia TB Control

More information

11/1/2017. Disclosures. Update In Tuberculosis, Indiana Outline/Objectives. Pathogenesis of M.tb Global/U.S. TB Burden, 2016

11/1/2017. Disclosures. Update In Tuberculosis, Indiana Outline/Objectives. Pathogenesis of M.tb Global/U.S. TB Burden, 2016 Disclosures Update In Tuberculosis, Indiana 2017 Bradley Allen, MD, PhD, FACP, FIDSA Indiana University School of Medicine Division of Infectious Diseases Roudebush VAMC Indianapolis Medical Consultant,

More information

Tuberculosis Impact in Boston Residents: 2014

Tuberculosis Impact in Boston Residents: 2014 Tuberculosis Impact in Boston Residents: 2014 BOSTON PUBLIC HEALTH COMMISSION Infectious Disease Bureau Communicable Disease Control Division Definitions Data include Boston residents only TB cases are

More information

TB Infection Who is Testing and Treating? TB Control and Elimination: Current Dilemma. Span of TB Control: 2010

TB Infection Who is Testing and Treating? TB Control and Elimination: Current Dilemma. Span of TB Control: 2010 TB Infection Who is Testing and Treating? Jennifer Flood, M.D., M.P.H. California Department of Public Health Tuberculosis Control Branch Jennifer.Flood@cdph.ca.gov 1 TB Control and Elimination: Current

More information

Global TB Burden, 2016 estimates

Global TB Burden, 2016 estimates TUBERCULOSIS EPIDEMIOLOGY LOCAL, STATE, NATIONAL, GLOBAL Office of Communicable Disease Epidemiology Global TB Burden, 216 estimates Total TB Estimated number of TB cases 1.4 million 14 per 1, Estimated

More information

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose

10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population

More information

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection? Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

INDEX CASE INFORMATION

INDEX CASE INFORMATION Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.

More information

TB in Foreign Born and High Risk Populations

TB in Foreign Born and High Risk Populations TB Nurse Case Management San Antonio, Texas December 8-10, 2009 TB in Foreign Born and High Risk Populations John J. Nava, M.D. December 9, 2009 Tuberculosis in High Risk Populations and the Foreign Born

More information

Tuberculosis Tools: A Clinical Update

Tuberculosis Tools: A Clinical Update Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary

More information

Tuberculosis in South West Centre: Annual review (2014 data) Data from 2000 to 2014

Tuberculosis in South West Centre: Annual review (2014 data) Data from 2000 to 2014 Tuberculosis in South West Centre: Annual review (2014 data) Data from 2000 to 2014 2 About Public Health England Public Health England exists to protect and improve the nation's health and wellbeing,

More information

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people

More information

Self-Study Modules on Tuberculosis

Self-Study Modules on Tuberculosis Self-Study Modules on Tuberculosis Transmission and Pathogenesis of Tube rc ulos is U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for HIV/AIDS,

More information

Annual surveillance report 2015

Annual surveillance report 2015 Annual surveillance report 215 Acknowledgements The Public Health Agency Northern Ireland gratefully acknowledges all those who contributed to this report, including; physicians, nurses, microbiologists,

More information

Tuberculosis in Alaska 1999

Tuberculosis in Alaska 1999 Department of Health and Social Services Division of Public Health Section of Epidemiology Karen Perdue, Commissioner Peter M. Nakamura, MD, MPH, Director John Middaugh, MD, Editor 361 C Street, Suite

More information

Report on Tuberculosis in California, 2012

Report on Tuberculosis in California, 2012 Golden Gate University School of Law GGU Law Digital Commons California Agencies California Documents 2012 Report on Tuberculosis in California, 2012 California Department of Public Health Follow this

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Epidemiology Robert Petrossian July 18, 2012 Robert Petrossian has the following disclosures to make: No conflict of interests No relevant

More information

Epidemiology of tuberculosis in Northern Ireland. Annual surveillance report 2007

Epidemiology of tuberculosis in Northern Ireland. Annual surveillance report 2007 Epidemiology of tuberculosis in Northern Ireland Annual surveillance report 27 Epidemiology of tuberculosis in Northern Ireland Annual surveillance report 27 Epidemiology of tuberculosis in Northern Ireland:

More information

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016 Recognizing MDR-TB in Children Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention 17-18 February 2016 Objectives Review the definitions and categorization of drugresistant tuberculosis Understand the

More information

Tuberculosis in Alameda County, 2011

Tuberculosis in Alameda County, 2011 Tuberculosis in Alameda County, 211 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a preventable and curable disease that remains one of the leading causes of death

More information

TB-Free California: How close are we? How can we get closer?

TB-Free California: How close are we? How can we get closer? TB-Free California: How close are we? How can we get closer? California TB Controllers Association April 21, 2015 Pennan Barry, MD, MPH Chief, Surveillance and Epidemiology Section Acknowledgments Local

More information

A Mobile Health Intervention Utilizing Community Partnership to Improve Access to Latent Tuberculosis Infection Treatment

A Mobile Health Intervention Utilizing Community Partnership to Improve Access to Latent Tuberculosis Infection Treatment A Mobile Health Intervention Utilizing Community Partnership to Improve Access to Latent Tuberculosis Infection Treatment Cassandra Garcia, MSN, RN, FNP-BC Mobile Clinic Provider Texas Children s Mobile

More information

ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM

ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM The form and content of the explanatory note is to: Inform those responsible for completing the DMR 164 Reporting Form - as to

More information

Epidemiology of Tuberculosis Denver TB Course

Epidemiology of Tuberculosis Denver TB Course Epidemiology of Tuberculosis Denver TB Course Randall Reves, MD, MSc Volunteer Clinician Denver Metro TB Program and Division of Infectious Diseases, Department of Medicine University of Colorado Denver

More information

Molecular Epidemiology of Extrapulmonary Tuberculosis

Molecular Epidemiology of Extrapulmonary Tuberculosis Molecular Epidemiology of Extrapulmonary Tuberculosis A Maryland State Review Jessie Torgersen PHASE Intern Maryland State Department of Health and Mental Hygiene Division of TB Control May 12, 2004 Outline

More information

The Tip of the Iceberg: Addressing Latent Tuberculosis Infection to Accelerate Tuberculosis Elimination

The Tip of the Iceberg: Addressing Latent Tuberculosis Infection to Accelerate Tuberculosis Elimination Four Corners TB and HIV Conference November 3, 2015 Durango, CO The Tip of the Iceberg: Addressing Latent Tuberculosis Infection to Accelerate Tuberculosis Elimination Philip LoBue, MD National Center

More information

Tuberculosis in NSW,

Tuberculosis in NSW, EPIREVIEW Tuberculosis in NSW, 2003 2007 Bridget A. O Connor, Lindy L. Fritsche, Amanda J. Christensen and Jeremy M. McAnulty Communicable Diseases Branch, NSW Department of Health Tuberculosis (TB) has

More information

Annual surveillance report 2016

Annual surveillance report 2016 Annual surveillance report 216 Acknowledgements The Public Health Agency Northern Ireland gratefully acknowledges all those who contributed to this report, including; physicians, nurses, microbiologists,

More information

Chapter 5 Treatment for Latent Tuberculosis Infection

Chapter 5 Treatment for Latent Tuberculosis Infection Chapter 5 Treatment for Latent Tuberculosis Infection Table of Contents Chapter Objectives.... 109 Introduction.... 111 Candidates for the Treatment of LTBI... 112 LTBI Treatment Regimens.... 118 LTBI

More information

Treatment of Active Tuberculosis

Treatment of Active Tuberculosis Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest

More information

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer The Public Health Impact of TB in the Correctional System Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer The Public Health Impact of TB in the Correctional System

More information

The authors assessed drug susceptibility patterns

The authors assessed drug susceptibility patterns Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division

More information

Jennifer Lam MPH candidate 2009 Johns Hopkins Bloomberg School of Public Health. Preceptors: Wendy Cronin, PhD MT(ASCP), Cathy Goldsborough, RN

Jennifer Lam MPH candidate 2009 Johns Hopkins Bloomberg School of Public Health. Preceptors: Wendy Cronin, PhD MT(ASCP), Cathy Goldsborough, RN Jennifer Lam MPH candidate 2009 Johns Hopkins Bloomberg School of Public Health Preceptors: Wendy Cronin, PhD MT(ASCP), Cathy Goldsborough, RN Phase Symposium: May 6, 2009 Background & Rationale Maryland

More information

Please distribute a copy of this information to each provider in your organization.

Please distribute a copy of this information to each provider in your organization. HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to

More information

All you need to know about Tuberculosis

All you need to know about Tuberculosis All you need to know about Tuberculosis What is tuberculosis? Tuberculosis is an infectious disease that usually affects the lungs. Doctors make a distinction between two kinds of tuberculosis infection:

More information

Contact Investigation and Prevention in the USA

Contact Investigation and Prevention in the USA Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis

More information

Diagnosis and Treatment of Tuberculosis, 2011

Diagnosis and Treatment of Tuberculosis, 2011 Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is

More information

LATENT TUBERCULOSIS SCREENING AND TREATMENT:

LATENT TUBERCULOSIS SCREENING AND TREATMENT: LATENT TUBERCULOSIS SCREENING AND TREATMENT: TB or not TB Christopher Kwong, MD and William Rifkin, MD Week 14 Educational Objectives: 1. Understand who should be screened for latent TB infection and why

More information

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012 TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release

More information

TB the basics. (Dr) Margaret (DHA) and John (INZ)

TB the basics. (Dr) Margaret (DHA) and John (INZ) TB the basics (Dr) Margaret (DHA) and John (INZ) Question 1 The scientist who discovered M. tuberculosis was: A: Louis Pasteur B: Robert Koch C: Jean-Antoine Villemin D: Calmette and Guerin Question 2

More information

Tuberculosis (TB) Fundamentals for School Nurses

Tuberculosis (TB) Fundamentals for School Nurses Tuberculosis (TB) Fundamentals for School Nurses June 9, 2015 Kristin Gall, RN, MSN/Pat Infield, RN-TB Program Manager Marsha Carlson, RN, BSN Two Rivers Public Health Department Nebraska Department of

More information

Contact Investigation

Contact Investigation Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period

More information

LTBI: Who to Test & When to Treat

LTBI: Who to Test & When to Treat LTBI: Who to Test & When to Treat TB Intensive May 10 th, 2016 David Horne, MD, MPH Harborview Medical Center University of Washington DISCLOSURES I have no disclosures or conflicts of interest to report

More information

Descriptive Epidemiology Project: Tuberculosis in the. United States. MPH 510: Applied Epidemiology. Summer A 2014

Descriptive Epidemiology Project: Tuberculosis in the. United States. MPH 510: Applied Epidemiology. Summer A 2014 Descriptive Epidemiology Project: Tuberculosis in the United States MPH 510: Applied Epidemiology Summer A 2014 June 1, 2014 1 The white plague affected thousands upon thousands of people in the 18 th

More information

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 5/6/2011 Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Debra Stephens, RN, BSN, MPH April 27, 2011 Debra Stephens,

More information

TUBERCULOSIS CONTACT INVESTIGATION

TUBERCULOSIS CONTACT INVESTIGATION TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE May 8-11, 2018 TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the

More information

Tuberculosis in Wales Annual Report 2015

Tuberculosis in Wales Annual Report 2015 Tuberculosis in Wales Annual Report 2015 Author: Communicable Disease Surveillance Centre Date: 10/03/2016 Version: 1 Status: Final Intended Audience: Health Purpose and Summary of Document: This annual

More information

Tuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012

Tuberculosis. New TB diagnostics. New drugs.new vaccines. Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis New TB diagnostics. New drugs.new vaccines Dr: Hussein M. Jumaah CABM Mosul College of Medicine 23/12/2012 Tuberculosis (TB )is a bacterial disease caused by Mycobacterium tuberculosis (occasionally

More information

Latent Tuberculosis Best Practices

Latent Tuberculosis Best Practices Latent Tuberculosis Best Practices Last Updated September 7, 2016 LTBI Demographics in the US o 13million people in the US with LTBI (estimate) o In 2014, approximately 66% of TB cases in the United States

More information

Tuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set

Tuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set Tuberculosis in England 2018 report (presenting data to end of 2017) Tables and figures slide set Number of TB notifications and rates, England, 1971-2017 2 Tuberculosis in England: 2018 report, Office

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 7 References Related ACA Standards 4 th Edition Standards for Adult Correctional Institutions 4-4350, 4-4355 These guidelines are based on the recommendations of the American Thoracic Society

More information

Errors in Dx and Rx of TB

Errors in Dx and Rx of TB Errors in Dx and Rx of TB David Schlossberg, MD, FACP Professor of Medicine Temple University School of Medicine Medical Director, TB Control Program Philadelphia Department of Public Health TB Still a

More information

The American Experience with TB Elimination

The American Experience with TB Elimination Reaching the Goal of TB Elimination by 2035 March 3, 2015 The American Experience with TB Elimination John Jereb, M.D. Medical officer Division of Tuberculosis Elimination National Center for HIV/AIDS,

More information

Director, University Health Services. Medical Director

Director, University Health Services. Medical Director March 2011 Issued, Revised, or Reviewed) Approved by: Office of Student Affairs Director, University Health Services Medical Director SUBJECT: SCREENING OF HEALTH SERVICES STAFF FOR TUBERCULOSIS POLICY

More information

TB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research

TB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

has the following disclosures to make:

has the following disclosures to make: CLINICAL DIAGNOSIS AND MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH September 22, 2015 TB Nurse Case Management September 22 24, 2015 San Antonio. TX EXCELLENCE EXPERTISE INNOVATION Annie Kizilbash

More information

Pediatric Tuberculosis in Los Angeles County: An Update

Pediatric Tuberculosis in Los Angeles County: An Update Pediatric Tuberculosis in Los Angeles County: An Update Julie Higashi, MD PhD Director, Tuberculosis Control Program March 2, 2019 0 Pediatricians will be the driving force of TB elimination in California

More information

Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010

Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010 Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010 Epidemiology of Substance Abuse and Tuberculosis: Where is the Problem? Mary Long, MPSH; Heartland Phillip Lindsey, MD; OK State

More information

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017 Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has

More information